Molecule intelOpportunity: ModerateEssentialCrowded market

Ascorbic Acid

463 brands · 194 companies · product forms

ATC: G01AD03, S01XA15 1 DRAP alert

Opportunity snapshot

Launch attractiveness
49
Market saturation
100
Price room
100
Regulatory risk
50
463
brands
194
companies
Rs 64.45
median price
184
price points
330.39x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 4%

Price room

Across observed sources and strengths
CheapestRs 18.69
MedianRs 64.45
Most expensiveRs 6,175
Spread330.39×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 330.39x across 184 trusted points (Rs 18.69-6175.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Ascorbic Acid — each links to its own medicine page.

Regulatory alerts

Recall exposurelatest 2023-11-14
Recall Alert: Drug Product; Weena Syrup (Batch # L-090) by Swat Pharmaceuticals, Swat

Why this score

Launch attractiveness

40% supply-gap(45) + 25% price-variation(100) + 20% low-competition(0) + 15% supply-disruption(40), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

194 canonical companies and 463 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 330.39x across 184 trusted points (Rs 18.69-6175.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2023-11-14 incl. recall/safety.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.